Form D · Pharmaceuticals

MERITAGE PHARMA INC

San Diego, CA · CIK 0001432016

Offering snapshot reported Nov 16, 2011 · SEC filing

Reported sold: $6.5M
Investors reported: 10
Minimum accepted: $1
First sale: Jan 18, 2011

Fundraising history

Reported sold

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

Reported sold$2,000,001 → $6,500,002

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
Nov 16, 2011	Amendment	$6,500,002	$4,500,001vs Jan 27, 2011	10	SEC filing
Jan 27, 2011	Initial	$2,000,001	No comparison	10	SEC filing
Aug 27, 2009	Amendment	$29,972,053	No comparison	23	SEC filing
Apr 4, 2008	Paper	Not reported	No comparison	Not reported	SEC filing

Offering details

Securities: Equity
Exemptions: 06
Duration over one year: No
Business combination: No

Sales commissions: $0
Finders' fees: $0
Form D file number: 021-154484

Source: Form D, filed Nov 16, 2011. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
James C. Blair, Ph.D.	Director
Cam L. Garner	Director
Malcolm R. Hill	Executive
Elaine M. Phillips, Ph.D.	Director, Executive
Adam K. Simpson	Executive
Kenneth J. Widder, M.D.	Director

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:

12481 High Bluff Drive Suite 160
San Diego, CA, 92130